首页 > 最新文献

Gastroenterology and Hepatology最新文献

英文 中文
One-Year Comparative Effectiveness of Upadacitinib Versus Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study. 乌达帕替尼与托法替尼治疗溃疡性结肠炎的一年疗效比较:一项多中心队列研究。
Q2 Medicine Pub Date : 2024-07-01
{"title":"One-Year Comparative Effectiveness of Upadacitinib Versus Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 6","pages":"14-15"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345977/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease by Disease Location: Results From the EVOLVE Expansion Study. 按疾病部位划分,Vedolizumab 和 Ustekinumab 在对生物制剂过敏的克罗恩病患者中的实际临床疗效和安全性:EVOLVE 扩大研究的结果。
Q2 Medicine Pub Date : 2024-07-01
{"title":"Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn's Disease by Disease Location: Results From the EVOLVE Expansion Study.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 5","pages":"12-14"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Study in the IBS-C Management Continuum: Assessing Patient Response and Tailoring Treatment. 肠易激综合征(IBS-C)持续管理案例研究:评估患者反应,调整治疗方案。
Q2 Medicine Pub Date : 2024-07-01
Nitin K Ahuja
{"title":"A Case Study in the IBS-C Management Continuum: Assessing Patient Response and Tailoring Treatment.","authors":"Nitin K Ahuja","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7","pages":"383-427"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Super-Responders in Patients With Moderate-to-Severe Crohn's Disease Treated With Subcutaneous Infliximab Maintenance Therapy: A Post Hoc Analysis of the LIBERT Y-CD Study. 皮下注射英夫利西单抗维持治疗的中重度克罗恩病患者中的超级应答者:LIBERT Y-CD研究的事后分析。
Q2 Medicine Pub Date : 2024-07-01
{"title":"Super-Responders in Patients With Moderate-to-Severe Crohn's Disease Treated With Subcutaneous Infliximab Maintenance Therapy: A Post Hoc Analysis of the LIBERT Y-CD Study.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 5","pages":"14-15"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142082587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended Induction Response Over Time in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab in the LUCENT-1 and -2 Trials. LUCENT-1和-2试验中使用米利珠单抗治疗的中度至重度活动性溃疡性结肠炎患者的诱导反应随时间推移而延长
Q2 Medicine Pub Date : 2024-07-01
{"title":"Extended Induction Response Over Time in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab in the LUCENT-1 and -2 Trials.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 6","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis in the Phase 3 INSPIRE and COMMAND Studies. INSPIRE和COMMAND三期研究中,利桑珠单抗对中度至重度活动性溃疡性结肠炎患者的作用。
Q2 Medicine Pub Date : 2024-07-01
{"title":"Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis in the Phase 3 INSPIRE and COMMAND Studies.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 6","pages":"11-13"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse Events Associated With Proton Pump Inhibitors: Fact vs Fiction. 与质子泵抑制剂相关的不良事件:事实与虚构
Q2 Medicine Pub Date : 2024-07-01
Paul Moayyedi
{"title":"Adverse Events Associated With Proton Pump Inhibitors: Fact vs Fiction.","authors":"Paul Moayyedi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7","pages":"421-424"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Management of Patients With Alcohol-Associated Hepatitis. 目前对酒精相关性肝炎患者的管理。
Q2 Medicine Pub Date : 2024-07-01
Brian P Lee
{"title":"Current Management of Patients With Alcohol-Associated Hepatitis.","authors":"Brian P Lee","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7","pages":"401-403"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Mirikizumab on Clinical and Endoscopic Outcomes After 1 Anti-TNF Failure in Patients With Moderately to Severely Active Ulcerative Colitis. 米利珠单抗对中度至重度活动性溃疡性结肠炎患者一次抗肿瘤坏死因子治疗失败后的临床和内镜检查结果的影响
Q2 Medicine Pub Date : 2024-07-01
{"title":"Effect of Mirikizumab on Clinical and Endoscopic Outcomes After 1 Anti-TNF Failure in Patients With Moderately to Severely Active Ulcerative Colitis.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 6","pages":"13-14"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Relevance of Baseline and Change in Urgency Numeric Rating Scale Score for Mirikizumab Treatment for Ulcerative Colitis. 米利珠单抗治疗溃疡性结肠炎的基线和急迫性数值评定量表评分变化的临床意义
Q2 Medicine Pub Date : 2024-07-01
{"title":"Clinical Relevance of Baseline and Change in Urgency Numeric Rating Scale Score for Mirikizumab Treatment for Ulcerative Colitis.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"20 7 Suppl 6","pages":"10-11"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology and Hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1